Form 6-K Theratechnologies Inc. For: Sep 12
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2025.
Commission File Number 001-35203
Theratechnologies Inc.
(Translation of registrant’s name into English)
2015 Peel Street, Suite 1100
Montreal, Quebec
H3A 1T8, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
☒ Form 20-F ☐ Form 40-F
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| THERATECHNOLOGIES INC. | ||
| By: |
/s/ Jocelyn Lafond | |
| Name: |
Jocelyn Lafond | |
| Title: |
General Counsel and Corporate Secretary |
Date: September 12, 2025
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Sheri and Les Biller Family Foundation to Distribute Brave Barbie and Brave Ken Dolls to Cancer Care Organizations Serving Children and Families across the Country
- JFK New Terminal One Releases ESG Report Highlighting Innovation, Energy Resilience and Sustainability Progress
- SBS CyberSecurity Launches Converge Lab Podcast for Business and Risk Leaders
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
